Monographie - Insulin aspart - Stabilis 4.0

Last update :
29/10/2024

Glucose-lowering

Insulin aspart

injection

Stability in solutions

Stability of mixtures

Factors which affect stability

Compatibility

Route of administration

References

pdf

Tradename

Tradename

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Insuline aspartate	France
Novolog	Australia, Austria, Belgium, Denmark, United Arab Emirates, United States of America
Novomix	Mexico
Novorapid	Argentina, Canada, Chile, Denmark, Egypt, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, Iran, Italy, Japan, Luxembourg, Malaysia, Mexico, Morocco, Netherlands, New Zealand, Norway, Peru, Poland, Romania, Saudi Arabia, Spain, Sweden, Switzerland, Turkey, United States of America, Venezuela

References

injection

References : Insulin aspart

	Type	Publication
1508	Journal	Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F. Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU. EJHP 2015 ;22:123-124.
2468	Journal	Mohnicke M, Blecher A, Beichert K, Bidlingmaier B, Todt E-J, Dette C, Rotthaeuser B, Mukherjee B. In vitro Stability of Biosimilar Insulin Aspart SAR341402 in the Medtronic MiniMed Insulin Pumps. J Pharm Sci 2023 ; 112: 963-973.
4433	Journal	Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K. Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications Clin Ther 2020 ; 42, 3: 475-485.
4521	Journal	Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B. Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit. Pharmaceutical Technology in Hospital Pharmacy 2020

Mentions Légales